Research Triangle Park, NC and San Francisco, CA (PRWEB) October 31, 2013
Veracity Logic, a provider of interactive web and voice technology solutions (IVR/IWR) for clinical trial management, and Medrio, a leading provider of Electronic Data Capture and eClinical Tools, jointly announce the completion of a real time web services interface between their two eClinical platforms.
“We are pleased to partner with Medrio in building this real time web services interface between our products. This interface will create a seamless experience for our users. When clinical data is added or updated in either the Veracity Logic VLIRT™ system or the Medrio EDC system, the two systems will stay synchronized in real time. By having users enter data in only one system, we reduce data entry errors and end-of-study data reconciliation requirements,” said David Goldston, Managing Director of Veracity Logic (VL)."
“Medrio is excited to develop this relationship with Veracity Logic given the complementary nature of our products and the benefits to our eClinical users. This interface provides better data faster and simplifies the work for our customers,” said Scott Weidley, Sr. Director of Sales and Marketing at Medrio.
About Veracity Logic
Veracity Logic is a provider of software systems for clinical study management including interactive web and voice response technology (IVR/IWR) used to manage randomization, clinical supply inventory, and subject diaries or electronic patient reported outcomes. Founded in 2005, Veracity Logic is located in Research Triangle Park, NC. Additional information on Veracity Logic is available at http://www.veracitylogic.com.
About Medrio, Inc.
Medrio offers an integrated eClinical Software as a Service (SaaS) platform with a fully hosted Electronic Data Capture (EDC) system that drastically reduces study timelines and costs by putting study managers in control of their studies. By enabling studies to be built completely online without the need for any custom development, Medrio eClinical software allows studies to be ready in days instead of weeks. Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by a number of leading contract research organizations (CROs), as well as biopharmaceutical and device companies.Founded in 2005, Medrio is headquartered in the San Francisco Bay Area. For more information, visit http://www.medrio.com.